Cyanamide-induced activation of the hypothalamo-pituitary-adrenal axis

被引:0
|
作者
Kinoshita, H [1 ]
Jessop, DS [1 ]
Finn, DP [1 ]
Harbuz, MS [1 ]
机构
[1] Univ Bristol, Bristol Royal Infirm, Dept Clin Med, Div Med, Bristol BS2 8HW, Avon, England
关键词
arginine vasopressin mRNA; autoradiographic method; hypothalamo-pituitary-adrenal axis; corticotrophin releasing factor mRNA; cyanamide;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study investigated the effects of acute administration of cyanamide (a potent inhibitor of aldehyde dehydrogenase used to treat alcoholics), on the hypothalamo-pituitary adrenal (HPA)-axis. Cyanamide resulted in a significant increase in arginine vasopressin mRNA and corticotrophjn releasing factor (CRF) mRNA in the parvocellular cells of the paraventricular nucleus and proopiomelanocortin (POMC) mRNA in the anterior pituitary, Plasma corticosterone concentrations were elevated by a range of doses of cyanamide which were maintained in the high dose group at 4 h following administration. These results suggest that cyanamide is able to activate the HPA axis at all levels of the axis, Arginine vasopressin mRNA, in the parvocellular cells of the paraventricular nucleus is an important component of the stress response. Silver grain counting of emulsion dipped slides is commonly used for its evaluation following in-situ hybridization, This method is however, not entirely satisfactory and very time-consuming. We compared this method with a film autoradiographic method, and show that the film autoradiographic method is valid for the determination of arginine vasopressin mRNA in the parvocellular cells of the paraventricular nucleus.
引用
收藏
页码:255 / 262
页数:8
相关论文
共 50 条
  • [1] Hypothalamo-pituitary-adrenal axis activation by administration of cyanamide: a potent inhibitor of aldehyde dehydrogenase
    Kinoshita, H
    Harbuz, MS
    Jessop, DS
    Finn, DP
    Ameno, S
    Ameno, K
    Kubota, T
    Ijiri, I
    FORENSIC SCIENCE INTERNATIONAL, 2000, 113 (1-3) : 397 - 402
  • [2] Endomorphins and activation of the hypothalamo-pituitary-adrenal axis
    Coventry, TL
    Jessop, DS
    Finn, DP
    Crabb, MD
    Kinoshita, H
    Harbuz, MS
    JOURNAL OF ENDOCRINOLOGY, 2001, 169 (01) : 185 - 193
  • [3] The hypothalamo-pituitary-adrenal axis
    Sridhar, GR
    NATIONAL MEDICAL JOURNAL OF INDIA, 1998, 11 (04): : 201 - 201
  • [4] Hypothalamo-pituitary-adrenal axis and chronic immune activation
    Harbuz, MS
    Chover-Gonzalez, AJ
    Jessop, DS
    NEUROENDOCRINE AND NEURAL REGULATION OF AUTOIMMUNE AND INFLAMMATORY DISEASE: MOLECULAR, SYSTEMS, AND CLINICAL INSIGHTS, 2003, 992 : 99 - 106
  • [5] CORTICOTHERAPY AND HYPOTHALAMO-PITUITARY-ADRENAL AXIS
    BLOCHMICHEL, H
    GORINS, A
    THEVENET, M
    PRESSE MEDICALE, 1970, 78 (13): : 599 - +
  • [6] ASSESSING THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS
    AXELROD, L
    LANCET, 1988, 2 (8604): : 215 - 216
  • [7] Oxytocin and hypothalamo-pituitary-adrenal axis
    Yegen, Berrak C.
    MARMARA PHARMACEUTICAL JOURNAL, 2010, 14 (02) : 61 - 66
  • [8] Exercise and the Hypothalamo-Pituitary-Adrenal Axis
    Duclos, Martine
    Tabarin, Antoine
    SPORTS ENDOCRINOLOGY, 2016, 47 : 12 - 26
  • [9] EFFECTS OF LITHIUM ON THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS
    SUGAWARA, M
    HASHIMOTO, K
    HATTORI, T
    TAKAO, T
    SUEMARU, S
    OTA, Z
    ENDOCRINOLOGIA JAPONICA, 1988, 35 (05): : 655 - 663
  • [10] GH secretagogues and hypothalamo-pituitary-adrenal axis
    Boscaro, M
    Mancini, T
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2003, 26 (03) : 190 - 191